Daclizumab Subcutaneous and Humalog Mix 50/50
Determining the interaction of Daclizumab Subcutaneous and Humalog Mix 50/50 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: insulin lispro / insulin lispro protamine
Brand name: Humalog Mix 50/50, Humalog Mix 50/50 KwikPen, Humalog Mix 75/25, Humalog Mix 75/25 KwikPen, HumaLOG Mix 75/25 Pen, HumaLOG Mix 50/50 Pen
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Humalog Mix 50/50 (Insulin Lispro Protamine and Insulin Lispro (Pens))
- Daclizumab Subcutaneous-HumaLog Mix 50/50 (Insulin Lispro Protamine and Insulin Lispro (Vials))
- Daclizumab Subcutaneous-Humalog Mix 50/50 KwikPen
- Daclizumab Subcutaneous-Humalog Mix 75/25
- Daclizumab Subcutaneous-Humalog Mix 75/25 (Insulin Lispro Protamine and Insulin Lispro (Pens))
- Daclizumab Subcutaneous-HumaLog Mix 75/25 (Insulin Lispro Protamine and Insulin Lispro (Vials))
- Humalog Mix 50/50-Dacogen
- Humalog Mix 50/50-Dacomitinib
- Humalog Mix 50/50-Dactinomycin
- Humalog Mix 50/50-Dactinomycin Injection
- Humalog Mix 50/50-Dactinomycin Intravenous
- Humalog Mix 50/50-Daklinza